﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Hamadan University of Medical Sciences</PublisherName>
      <JournalTitle>Journal of Research in Health Sciences</JournalTitle>
      <Issn>2228-7795</Issn>
      <Volume>16</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2016</Year>
        <Month>10</Month>
        <DAY>03</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>Co-Infections and Sero-Prevalence of HIV, Syphilis, Hepatitis B and C Infections in Sexually Transmitted Infections Clinic Attendees of Tertiary Care Hospital in North India</ArticleTitle>
    <FirstPage>162</FirstPage>
    <LastPage>165</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Sonali</FirstName>
        <LastName>Bhattar</LastName>
      </Author>
      <Author>
        <FirstName>Prabhav</FirstName>
        <LastName>Aggarwal</LastName>
      </Author>
      <Author>
        <FirstName>Satyendra Kumar</FirstName>
        <LastName>Sahani</LastName>
      </Author>
      <Author>
        <FirstName>Preena</FirstName>
        <LastName>Bhalla</LastName>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">
      </ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2016</Year>
        <Month>06</Month>
        <Day>23</Day>
      </PubDate>
    </History>
    <Abstract> Background: HIV, syphilis, hepatitis B and C (HBV &amp; HCV) infections modify the epidemiology and presentation of each other. This study aimed to estimate the seroprevalence of these infections and their co-infections in sexually transmitted infections (STI) clinic attendees in New Delhi, India. Methods: A retrospective study including 220 patients was conducted during May 2014 through December 2014. Serodiagnosis of HIV was performed as per Strategy III of NACO guidelines; syphilis by VDRL followed by TPHA; HBV and HCV by rapid immuno-chromatographic test followed by ELISA. Results: Male subjects were slightly more in number as compared to females (56.36% vs. 43.63%). Twelve (5.45%), 14 (6.36%), three (1.36 %) and one (0.45%) were reactive for HIV, VDRL, HBV and HCV, respectively. Three were both HIV and syphilis positive and one was both HIV and HBV positive; no co-infections of HBV/HCV, HIV/HBV/HCV and HIV/HBV/HCV/syphilis coexisted. Conclusions: High prevalence of HIV, HBV, HCV and syphilis in STI clinic attendees mandate routine screening to detect co-infections and follow prompt therapy in order to minimize their sequelae.</Abstract>
  </Article>
</ArticleSet>